Gujarat Inject (Kerala) share news, announcements and annual reports
BSE: 524238Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹11.22.
30 Oct: open ₹11.29, high ₹11.54, low ₹10.77
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹163 Cr2,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 54.64
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.82
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 32.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,44,603
Gujarat Inject (Kerala) share news and announcements
407 announcements, routine notices left out, newest first. Page 6 of 9.
Feb 2021
12 Feb · Results
12 Feb · Board meeting
8 Feb · Board meeting
Meeting on 12 Feb 2021: quarterly results
Jan 2021
13 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2020
12 Nov · Results
12 Nov · Board meeting
5 Nov · Board meeting
Meeting on 12 Nov 2020: quarterly results
Oct 2020
26 Oct · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Half Year Ended On 30Th September, 2020
21 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 07 Oct · Reg. 34 (1) Annual Report
6 Oct · Brief Profile Of Company Secretary And Compliance Officer Of The Company.
3 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2020
25 Sep · Management
9 Sep · Board meeting
Meeting on 15 Sep 2020: quarterly results7 Sep · Board meeting
Meeting on 7 Sep 2020: annual general meeting
Jul 2020
27 Jul · Board meeting
Meeting on 31 Jul 2020: audited results15 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2020
18 Jun · Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
May 2020
14 May · Certificate Under Regulation 40(9) Of SEBI (LODR) Regualtions, 2015.
9 May · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2020
6 Mar · Reg. 34 (1) Annual Report
6 Mar · Reg. 34 (1) Annual Report
Feb 2020
3 Feb · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....3 Feb · Board meeting
3 Feb · Board meeting
3 Feb · Board meeting
3 Feb · Board meeting
1 Feb · Submission Of Certificate Under Regulation 40 (9, 10) Of Listing Obligation And Disclosure Requirement Or The Half Year Ended On 31St March, 2017.
1 Feb · Board meeting
1 Feb · Submission Of Certificate Under Regulation 40 (9, 10) Of Listing Obligation And Disclosure Requirement.
Jan 2020
23 Jan · Results
20 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....